23
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Gemcitabine
Gemcitabine administered intravenously over 30 minutes on days 1, 8 and 15 of each cycle at a fixed dose of 1000mg/m2.
Capecitabine
Capecitabine administered orally at 1660 mg/m2/day divided into two doses for 21 days followed by a week-off.
ZD6474
Administered orally at 300 mg/day once daily. One cycle will consist of 28 days
University of Colorado Denver, Aurora
Collaborators (1)
AstraZeneca
INDUSTRY
University of Colorado, Denver
OTHER